TBL1XR1: A Potential Drug Target and Biomarker for F-Box-Like/WD Repeat-Containing Proteins

Target Name: TBL1XR1

NCBI ID: G79718

TBL1XR1

TBL1XR1: A Potential Drug Target and Biomarker for F-Box-Like/WD Repeat-Containing Proteins

The protein TBL1XR1 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. TBL1XR1 is a member of the F-box-like/WD repeat-containing protein family, which is characterized by the presence of an F-box and a WD repeat in the protein sequence. In this article, we will provide an overview of TBL1XR1, its potential drug target status, and its potential as a biomarker for various diseases.

Overview of TBL1XR1

TBL1XR1 is a 21-kDa protein that is expressed in various tissues, including muscle, brain, and peripheral blood cells. It is characterized by the presence of an F-box and a WD repeat in its sequence. The F-box is a protein domain that is commonly found in various proteins and is involved in protein-protein interactions and signaling. The WD repeat is a specific type of repeat that is also found in various proteins and is involved in protein stability and stability-related functions.

Expression and Localization of TBL1XR1

TBL1XR1 is expressed in various tissues and cells and has been shown to localize to the endoplasmic reticulum (ER) and the cytoplasm. It has also been shown to be involved in the regulation of protein translation and to play a role in the development and maintenance of muscle mass.

Potential Drug Target Status

TBL1XR1 has been identified as a potential drug target due to its unique structure and its involvement in various signaling pathways. TBL1XR1 has been shown to play a role in the regulation of protein function and stability, which is related to the regulation of cellular processes that are critical for the survival and growth of cells.

In addition, TBL1XR1 has been shown to be involved in the regulation of muscle growth and maintenance, which is related to the development and treatment of muscle-related diseases, such as cancer and neurodegenerative diseases.

Potential as a Biomarker

TBL1XR1 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. TBL1XR1 has been shown to be involved in the regulation of cellular processes that are critical for the development and progression of these diseases.

In addition, TBL1XR1 has been shown to be involved in the regulation of inflammation, which is related to the development and treatment of autoimmune disorders.

Conclusion

TBL1XR1 is a protein that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and its involvement in various signaling pathways make it an attractive target for drug development. Further research is needed to determine the full potential of TBL1XR1 as a drug and biomarker.

Protein Name: TBL1X/Y Related 1

Functions: F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation

The "TBL1XR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TBL1XR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets